Abstract
The aim of the study wasto evaluate the long-term results ofsurgicaltreatment of patients with pharmacoresistant epilepsy.Materials and methods. A retrospective analysis of treatment outcomes in patients with drug-resistant temporal lobe epilepsy was performed. According to the inclusion and exclusion criteria, 96 patients were selected for the study. Group 1 contained 49 operated patients with MR-positive epilepsy and Group 2 contained 47 operated patients with MR-ne‑ gative epilepsy. The control group consisted of 53 unoperated patients. The outcomes ofsurgical treatment were assessed after 6, 12, and 24 months. Results. Unfavorable outcomes occurred more frequently among nonoperated patients compared to both surgical groups (p <0.001). The probability of the 2-year remission after surgery in operated MRI positive patients was 60 %, in MRI negative group was 45 %, and in conservative group – only 2 %. The mean duration of the seizures-free period was greatest̆in the MRI positive surgical group (15.4 ± 1.5 months), and shortest in the control group (3.3 ± 0.9 months).Conclusion. The presented results prove the effectiveness and safety of surgical treatment of patients with temporal lobe epilepsy.
Highlights
Цель исследования – оценить отдаленные результаты хирургического лечения пациентов с фармакорезистентной височной эпилепсией
Отдаленные результаты лечения фармакорезистент‐ ных форм височной эпилепсии
According to the inclusion and exclusion criteria, 96 patients were selected for the study
Summary
Цель исследования – оценить отдаленные результаты хирургического лечения пациентов с фармакорезистентной височной эпилепсией. Выполнен ретроспективный анализ исходов лечения пациентов с фармакорезистентной височной эпилепсией. Исходы хирургического лечения оценивали через 6, 12 и 24 мес. Неблагоприятные исходы встречались чаще в группе неоперированных пациентов, чем в обеих груп‐ пах оперированных пациентов (р
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have